ReviewBMC medical genomics2025
Prenatally diagnosed chromosome 1p36 deletions: a retrospective case series, literature review, and genotype-phenotype correlations.
Review in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChromosome 1p36 deletion syndrome is the most common terminal autosomal deletion disorder. While postnatal features are well-defined, prenatal characterization remains less comprehensive. This study aims to delineate the prenatal sonographic and genetic spectrum of this syndrome and explore genotype-phenotype correlations.
methodsA retrospective analysis was conducted on 21 consecutive prenatally diagnosed cases of 1p36 deletion (2017–2025) from a single tertiary center. Data on maternal demographics, ultrasound findings, genetic results, inheritance patterns, and pregnancy outcomes were collected. A pooled analysis included 10 isolated cases (with complete ultrasound data) from our cohort and 33 previously reported cases.
resultsThe cohort demonstrated a strong female predominance (71.4%, 15/21). Fifteen (71.4%) involved isolated 1p36 deletions, while six (28.6%) exhibited additional chromosomal aberrations. Pooled analysis of 43 prenatally diagnosed isolated cases (10 current and 33 published) revealed brain anomalies to be the most common prenatal feature (58.1%, 25/43), with ventriculomegaly (37.2%, 16/43), corpus callosum hypoplasia (9.3%, 4/43), and choroid plexus cysts (9.3%, 4/43) being the most frequent subtypes. Cardiac defects were observed in 39.5% (17/43) of cases, predominantly atrial/ventricular septal defects (ASD/VSD, 23.3%, 10/43) and Ebstein anomaly (11.6%, 5/43). Other frequently observed features included increased nuchal translucency (16.3%, 7/43) and single umbilical artery (14%, 6/43). Parental genetic analysis demonstrated de novo deletions in 80.0% (12/15) of cases, while 20.0% (3/15) were inherited from phenotypically normal parents.
conclusionsCongenital brain anomalies (particularly ventriculomegaly) and cardiac defects are hallmark prenatal features of isolated 1p36 deletion syndrome. Our findings underscore the role of key genes (RERE, SPEN, PRDM16, MMP23B) in shaping the phenotype and highlight the importance of parental genetic testing in counseling, given the potential for inherited variants with variable expressivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.